Research On Strategy And Analysis For Quality Cost Control Of ZY Pharmaceutical Company

There are more than four thousand pharmaceutical company in China, but no more than 8% on international medical market. Deficiency in Pat Med and well-known MED, we are fighting for the price. In the national Pharmaceutical industry are more and disperse factories, high lacking innovation capacity, the enterprise must develop the manufacture level and improve the innovation capacity to get the success of competition. How can we attain a sufficient competitive advantage?The enterprise must develop the manufacture level and improve the innovation capacity to get the success of competition. However, all of means must be based on the foundation of producing good quality products, and only the good quality and the lower cost can attain a sufficient competitive advantage.As a state-owned company, ZY Pharmaceutical Company has passed GMP accreditation overall. How to ensure that the quality management system can operate normally and efficiently in order to improve product quality and even the whole Company's benefit is very important issue. How to eliminate waste produced in our workshop, Lean Production will tell us. This paper gives a general description on the quality management system of ZY Pharmaceutical Company and a detailed analysis on the existing problems based on the requirements for quality management and quality cost control.In accordance with question of quality management system and quality cost , the Strategy is :1.The waste produced in our workshop will be eliminate by LP;2.Quality concept will be changed through recreating quality culture;3.ZY Pharmaceutical Company will attain new sucess by PDCA.